|
||||||||||||||||||||||||||
| SEC Info℠ | | | Home | | | Search | | | My Interests | | | Help | | | Sign In | | | Please Sign In | |||||||
|
||||||||||||||||||||||||||
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 12/02/22 Biopower Operations Corp. 10-Q 8/31/22 40:3.8M M2 Compliance LLC/FA |
Document/Exhibit Description Pages Size
1: 10-Q Quarterly Report HTML 893K
2: EX-31.1 Certification -- §302 - SOA'02 HTML 17K
3: EX-31.2 Certification -- §302 - SOA'02 HTML 17K
4: EX-32.1 Certification -- §906 - SOA'02 HTML 15K
10: R1 Cover HTML 62K
11: R2 Consolidated Balance Sheets HTML 97K
12: R3 Consolidated Balance Sheets (Parenthetical) HTML 36K
13: R4 Consolidated Statements of Operations HTML 63K
14: R5 Consolidated Statements of Cash Flows HTML 83K
15: R6 Consolidated Statements of Changes in HTML 82K
Stockholders' Deficit (Unaudited)
16: R7 Organization HTML 41K
17: R8 Summary of Significant Accounting Policies HTML 56K
18: R9 Notes Payable and Convertible Debt HTML 51K
19: R10 Related Party Transactions HTML 69K
20: R11 Senior Promissory Note - related party HTML 21K
21: R12 Stockholders? deficit HTML 48K
22: R13 Commitments and Contingencies HTML 35K
23: R14 Subsequent Events HTML 21K
24: R15 Summary of Significant Accounting Policies HTML 92K
(Policies)
25: R16 Notes Payable and Convertible Debt (Tables) HTML 21K
26: R17 Related Party Transactions (Tables) HTML 18K
27: R18 Organization (Details Narrative) HTML 64K
28: R19 Summary of Significant Accounting Policies HTML 79K
(Details Narrative)
29: R20 Schedule of Notes Payable (Details) HTML 30K
30: R21 Notes Payable and Convertible Debt (Details HTML 63K
Narrative)
31: R22 Schedule of Amount Owed on Prepayment of Diagonal HTML 21K
Lending Note (Details)
32: R23 Related Party Transactions (Details Narrative) HTML 148K
33: R24 Senior Promissory Note - related party (Details HTML 27K
Narrative)
34: R25 Stockholders? deficit (Details Narrative) HTML 118K
35: R26 Commitments and Contingencies (Details Narrative) HTML 49K
38: XML IDEA XML File -- Filing Summary XML 64K
36: XML XBRL Instance -- from10-q_htm XML 807K
37: EXCEL IDEA Workbook of Financial Reports XLSX 85K
6: EX-101.CAL Inline XBRL Taxonomy Extension Calculation XML 87K
Linkbase Document -- bopo-20220831_cal
7: EX-101.DEF Inline XBRL Taxonomy Extension Definition Linkbase XML 451K
Document -- bopo-20220831_def
8: EX-101.LAB Inline XBRL Taxonomy Extension Label Linkbase XML 672K
Document -- bopo-20220831_lab
9: EX-101.PRE Inline XBRL Taxonomy Extension Presentation XML 541K
Linkbase Document -- bopo-20220831_pre
5: EX-101.SCH Inline XBRL Taxonomy Extension Schema Document -- XSD 92K
bopo-20220831
39: JSON XBRL Instance as JSON Data -- MetaLinks 255± 353K
40: ZIP XBRL Zipped Folder -- 0001493152-22-034278-xbrl Zip 175K
Exhibit 31.2
CERTIFICATIONS
I, Paul Christopher Walton, certify that:
1. I have reviewed this quarterly report on Form 10-Q for the quarterly period ended August 31, 2022 of BioPower Operations Corporation;
2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4. The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
(c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
(d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
5. The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):
(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.
| Date: December 2, 2022 | /s/ Paul Christopher Walton |
| Paul Christopher Walton | |
| Chief Operating Officer (principal financial officer and principal accounting officer) |
C:
| This ‘10-Q’ Filing | Date | Other Filings | ||
|---|---|---|---|---|
 | ||||
| Filed on: | 12/2/22 | None on these Dates | ||
| For Period end: | 8/31/22 | |||
| List all Filings | ||||